{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:53:58Z","timestamp":1790290438722,"version":"4.1.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T00:00:00Z","timestamp":1524441600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T00:00:00Z","timestamp":1524441600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["HORM CANC"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s12672-018-0332-y","type":"journal-article","created":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T15:10:01Z","timestamp":1524496201000},"page":"240-253","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The Impact of Hormonal Contraceptives on Breast Cancer Pathology"],"prefix":"10.1007","volume":"9","author":[{"given":"Jesse A.","family":"Dorchak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sifat","family":"Maria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph L.","family":"Guarinoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anette","family":"Duensing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Somiari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Cavanaugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"Deyarmin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joji","family":"Iida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig D.","family":"Shriver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula A.","family":"Witt-Enderby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,23]]},"reference":[{"key":"332_CR1","unstructured":"American Cancer Society. Cancer facts & figures 2016. 2016. Journal. http:\/\/www.cancer.org\/acs\/groups\/content\/@research\/documents\/document\/acspc047079.pdf"},{"key":"332_CR2","unstructured":"Centers for Disease Control and Prevention: Cancer among women. 2015. Journal . http:\/\/www.cdc.gov\/cancer\/dcpc\/data\/women.htm"},{"issue":"11","key":"332_CR3","doi-asserted-by":"publisher","first-page":"e79695","DOI":"10.1371\/journal.pone.0079695","volume":"8","author":"A Amadou","year":"2013","unstructured":"Amadou A, Fabre A, Torres-Mej\u00eda G, Ortega-Olvera C, Angeles-Llerenas A, McKenzie F, Biessy C, Hainaut P, Romieu I (2013) Hormonal therapy and risk of breast cancer in Mexican women. PLoS One 8(11):e79695","journal-title":"PLoS One"},{"issue":"22","key":"332_CR4","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.1200\/JCO.2010.33.7964","volume":"29","author":"NF Boyd","year":"2011","unstructured":"Boyd NF, Melnichouk O, Martin LJ, Hislop G, Chiarelli AM, Yaffe MJ, Minkin S (2011) Mammographic density, response to hormones, and breast cancer risk. J Clin Oncol 29(22):2985\u20132992","journal-title":"J Clin Oncol"},{"issue":"5","key":"332_CR5","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1177\/2042098614548857","volume":"5","author":"Brynhildsen","year":"2014","unstructured":"Brynhildsen (2014) Combined hormonal contraceptives: prescribing patterns, compliance, and benefits versus risks. Therapeutic advances in drug safety 5(5):201\u2013213","journal-title":"Therapeutic advances in drug safety"},{"issue":"1","key":"332_CR6","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/pon.2049","volume":"22","author":"KT Bui","year":"2013","unstructured":"Bui KT, Wakefield CE, Kasparian NA, Tyler J, Abbott J, Tucker K (2013) Oral contraceptive use in women at increased risk of breast\/ovarian cancer: knowledge and attitudes. Psycho-Oncology 22(1):228\u2013232","journal-title":"Psycho-Oncology"},{"issue":"11","key":"332_CR7","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1007\/s10552-013-0273-2","volume":"24","author":"JF Dorgan","year":"2013","unstructured":"Dorgan JF, Klifa C, Deshmukh S, Egleston BL, Shepherd JA, Kwiterovich PO, van Horn L, Snetselaar LG, Stevens VJ, Robson AM, Lasser NL, Hylton NM (2013) Menstrual and reproductive characteristics and breast density in young women. Cancer Causes Control 24(11):1973\u20131983","journal-title":"Cancer Causes Control"},{"issue":"1","key":"332_CR8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1524-4741.2011.01181.x","volume":"18","author":"A-K Imkampe","year":"2012","unstructured":"Imkampe A-K, Bates T (2012) Correlation of age at oral contraceptive pill start with age at breast cancer diagnosis. Breast J 18(1):35\u201340","journal-title":"Breast J"},{"key":"332_CR9","doi-asserted-by":"crossref","unstructured":"Lu, Yani, Ma, Huiyan, Malone, Kathleen E, Norman, Sandra A, et al. (2011) Oral contraceptive use and survival in women with invasive breast cancer. Cancer Epidemiology and Prevention Biomarkers","DOI":"10.1158\/1055-9965.EPI-11-0022"},{"issue":"33","key":"332_CR10","doi-asserted-by":"publisher","first-page":"4188","DOI":"10.1200\/JCO.2013.48.9021","volume":"31","author":"PG Moorman","year":"2013","unstructured":"Moorman PG, Havrilesky LJ, Gierisch JM, Coeytaux RR, Lowery WJ, Peragallo Urrutia R, Dinan M, McBroom AJ, Hasselblad V, Sanders GD, Myers ER (2013) Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis. J Clin Oncol 31(33):4188\u20134198","journal-title":"J Clin Oncol"},{"issue":"Suppl 1","key":"332_CR11","first-page":"S2","volume":"5","author":"HA Assi","year":"2013","unstructured":"Assi HA, Khoury KE, Dbouk H, Khalil LE et al (2013) Epidemiology and prognosis of breast cancer in young women. Journal of thoracic disease 5(Suppl 1):S2","journal-title":"Journal of thoracic disease"},{"issue":"6","key":"332_CR12","doi-asserted-by":"publisher","first-page":"752","DOI":"10.3109\/0284186X.2013.878471","volume":"53","author":"T Thorbjarnardottir","year":"2014","unstructured":"Thorbjarnardottir T, Olafsdottir EJ, Valdimarsdottir UA, Olafsson O, Tryggvadottir L (2014) Oral contraceptives, hormone replacement therapy and breast cancer risk: a cohort study of 16 928 women 48 years and older. Acta Oncol 53(6):752\u2013758","journal-title":"Acta Oncol"},{"issue":"23","key":"332_CR13","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1056\/NEJMoa1700732","volume":"377","author":"LS M\u00f8rch","year":"2017","unstructured":"M\u00f8rch LS, Skovlund CW, Hannaford PC, Iversen L, Fielding S, Lidegaard \u00d8 (2017) Contemporary hormonal contraception and the risk of breast cancer. N Engl J Med 377(23):2228\u20132239","journal-title":"N Engl J Med"},{"key":"332_CR14","unstructured":"World contraceptive patterns 2013. New York: United Nations, Department of Economic and Social Affairs Journal .(http:\/\/www.un.org\/en\/development\/desa\/population\/publications\/family\/contraceptive-wallchart-2013.shtml)"},{"key":"332_CR15","unstructured":"Current contraceptive status among women aged 15\u201344: United States, 2011\u20132013. 2014. Journal (Issue)"},{"issue":"1","key":"332_CR16","first-page":"41","volume":"11","author":"AE Schindler","year":"2013","unstructured":"Schindler AE (2013) Non-contraceptive benefits of oral hormonal contraceptives. International journal of endocrinology and metabolism 11(1):41\u201347","journal-title":"International journal of endocrinology and metabolism"},{"issue":"1","key":"332_CR17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.7205\/MILMED.172.1.9","volume":"172","author":"LA Christopher","year":"2007","unstructured":"Christopher LA, Miller L (2007) Women in war: operational issues of menstruation and unintended pregnancy. Mil Med 172(1):9\u201316","journal-title":"Mil Med"},{"issue":"3","key":"332_CR18","first-page":"479","volume":"99","author":"G Evans","year":"2015","unstructured":"Evans G, Sutton EL (2015) Oral contraception. Medical Clinics 99(3):479\u2013503","journal-title":"Medical Clinics"},{"issue":"4","key":"332_CR19","doi-asserted-by":"publisher","first-page":"213","DOI":"10.5114\/pm.2014.44996","volume":"13","author":"M Gambacciani","year":"2014","unstructured":"Gambacciani M, Levancini M (2014) Hormone replacement therapy and the prevention of postmenopausal osteoporosis. Przeglad menopauzalny = Menopause review 13(4):213\u2013220","journal-title":"Przeglad menopauzalny = Menopause review"},{"issue":"1","key":"332_CR20","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.whi.2010.08.006","volume":"21","author":"NC Powell-Dunford","year":"2011","unstructured":"Powell-Dunford NC, Cuda AS, Moore JL, Crago MS, Kelly AM, Deuster PA (2011) Menstrual suppression for combat operations: advantages of oral contraceptive pills. Womens Health Issues 21(1):86\u201391","journal-title":"Womens Health Issues"},{"issue":"11","key":"332_CR21","doi-asserted-by":"publisher","first-page":"3975","DOI":"10.1210\/jc.2015-2236","volume":"100","author":"CA Stuenkel","year":"2015","unstructured":"Stuenkel CA, Davis SR, Gompel A, Lumsden MA, Murad MH, Pinkerton JAV, Santen RJ (2015) Treatment of symptoms of the menopause: an Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism 100(11):3975\u20134011","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"4","key":"332_CR22","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/1097-0215(20000815)87:4<591::AID-IJC20>3.0.CO;2-C","volume":"87","author":"V Hoften","year":"2000","unstructured":"Hoften V, Carlijn B, Huibert P, Petra HM, Grobbee DE et al (2000) Long-term oral contraceptive use increases breast cancer risk in women over 55 years of age: the DOM cohort. Int J Cancer 87(4):591\u2013594","journal-title":"Int J Cancer"},{"issue":"4","key":"332_CR23","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.contraception.2011.08.007","volume":"85","author":"PA Marchbanks","year":"2012","unstructured":"Marchbanks PA, Curtis KM, Mandel MG, Wilson HG, Jeng G, Folger SG, McDonald JA, Daling JR, Bernstein L, Malone KE, Wingo PA, Simon MS, Norman SA, Strom BL, Ursin G, Weiss LK, Burkman RT, Spirtas R (2012) Oral contraceptive formulation and risk of breast cancer. Contraception 85(4):342\u2013350","journal-title":"Contraception"},{"issue":"11","key":"332_CR24","first-page":"1375","volume":"11","author":"M Kumle","year":"2002","unstructured":"Kumle M, Weiderpass E, Braaten T, Persson I et al (2002) Use of oral contraceptives and breast cancer risk. Cancer Epidemiology and Prevention Biomarkers 11(11):1375\u20131381","journal-title":"Cancer Epidemiology and Prevention Biomarkers"},{"issue":"2","key":"332_CR25","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1023\/A:1023006000760","volume":"14","author":"MD Althuis","year":"2003","unstructured":"Althuis MD, Brogan DD, Coates RJ, Daling JR, Gammon MD, Malone KE, Schoenberg JB, Brinton LA (2003) Breast cancers among very young premenopausal women (United States). Cancer Causes Control 14(2):151\u2013160","journal-title":"Cancer Causes Control"},{"issue":"6","key":"332_CR26","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1002\/ijc.11167","volume":"105","author":"V Dumeaux","year":"2003","unstructured":"Dumeaux V, Alsaker E, Lund E (2003) Breast cancer and specific types of oral contraceptives: a large Norwegian cohort study. Int J Cancer 105(6):844\u2013850","journal-title":"Int J Cancer"},{"issue":"5","key":"332_CR27","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s10552-004-8024-z","volume":"16","author":"V Dumeaux","year":"2005","unstructured":"Dumeaux V, Fournier A, Lund E, Clavel-Chapelon F (2005) Previous oral contraceptive use and breast cancer risk according to hormone replacement therapy use among postmenopausal women. Cancer Causes Control 16(5):537\u2013544","journal-title":"Cancer Causes Control"},{"issue":"3","key":"332_CR28","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1002\/ijc.11078","volume":"105","author":"SY Lee","year":"2003","unstructured":"Lee SY, Kim MT, Kim SW, Song MS, Yoon SJ (2003) Effect of lifetime lactation on breast cancer risk: a Korean women's cohort study. Int J Cancer 105(3):390\u2013393","journal-title":"Int J Cancer"},{"issue":"3","key":"332_CR29","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.annepidem.2005.02.015","volume":"16","author":"M-H Wu","year":"2006","unstructured":"Wu M-H, Chou Y-C, Yu J-C, Yu C-P, Wu CC, Chu CM, Yang T, Lai CH, Hsieh CY, You SL, Chen CJ, Sun CA (2006) Hormonal and body-size factors in relation to breast cancer risk: a prospective study of 11,889 women in a low-incidence area. Ann Epidemiol 16(3):223\u2013229","journal-title":"Ann Epidemiol"},{"issue":"7621","key":"332_CR30","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1136\/bmj.39289.649410.55","volume":"335","author":"PC Hannaford","year":"2007","unstructured":"Hannaford PC, Selvaraj S, Elliott AM, Angus V, Iversen L, Lee AJ (2007) Cancer risk among users of oral contraceptives: cohort data from the Royal College of General Practitioner\u2019s oral contraception study. BMJ 335(7621):651","journal-title":"BMJ"},{"issue":"10","key":"332_CR31","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1093\/aje\/kwm006","volume":"165","author":"S Shantakumar","year":"2007","unstructured":"Shantakumar S, Terry MB, Paykin A, Teitelbaum SL, Britton JA, Moorman PG, Kritchevsky SB, Neugut AI, Gammon MD (2007) Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk. Am J Epidemiol 165(10):1187\u20131198","journal-title":"Am J Epidemiol"},{"issue":"10","key":"332_CR32","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1002\/ijc.24232","volume":"124","author":"T Dorjgochoo","year":"2009","unstructured":"Dorjgochoo T, Shu X-O, Li H-L, Qian H-Z, Yang G, Cai H, Gao Y-T, Zheng W (2009) Use of oral contraceptives, intrauterine devices and tubal sterilization and cancer risk in a large prospective study, from 1996 to 2006. Int J Cancer 124(10):2442\u20132449","journal-title":"Int J Cancer"},{"issue":"4","key":"332_CR33","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1093\/aje\/kwn360","volume":"169","author":"L Rosenberg","year":"2008","unstructured":"Rosenberg L, Zhang Y, Coogan PF, Strom BL, Palmer JR (2008) A case-control study of oral contraceptive use and incident breast cancer. Am J Epidemiol 169(4):473\u2013479","journal-title":"Am J Epidemiol"},{"issue":"15","key":"332_CR34","doi-asserted-by":"publisher","first-page":"4078","DOI":"10.1158\/0008-5472.CAN-13-3400","volume":"74","author":"EF Beaber","year":"2014","unstructured":"Beaber EF, Buist DSM, Barlow WE, Malone KE, Reed SD, Li CI (2014) Recent oral contraceptive use by formulation and breast cancer risk among women 20 to 49 years of age. Cancer Res 74(15):4078\u20134089","journal-title":"Cancer Res"},{"key":"332_CR35","doi-asserted-by":"crossref","unstructured":"Hunter, David J, Colditz, Graham A, Hankinson, Susan E, Malspeis, Susan, et al., 2010, Oral contraceptive use and breast cancer: a prospective study of young women. Cancer Epidemiology and Prevention Biomarkers: p. cebp. 0747.2010","DOI":"10.1158\/1055-9965.EPI-10-0747"},{"issue":"1","key":"332_CR36","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s10552-009-9443-7","volume":"21","author":"M Kawai","year":"2010","unstructured":"Kawai M, Minami Y, Kuriyama S, Kakizaki M, Kakugawa Y, Nishino Y, Ishida T, Fukao A, Tsuji I, Ohuchi N (2010) Reproductive factors, exogenous female hormone use and breast cancer risk in Japanese: the Miyagi cohort study. Cancer Causes Control 21(1):135\u2013145","journal-title":"Cancer Causes Control"},{"issue":"6","key":"332_CR37","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.contraception.2013.08.008","volume":"88","author":"M Vessey","year":"2013","unstructured":"Vessey M, Yeates D (2013) Oral contraceptive use and cancer: final report from the Oxford\u2013Family Planning Association contraceptive study. Contraception 88(6):678\u2013683","journal-title":"Contraception"},{"key":"332_CR38","unstructured":"Lanfranchi, Angela (2014) Normal breast physiology: the reasons hormonal contraceptives and induced abortion increase breast-cancer risk. Issues L. & Med. 29: p. 135"},{"key":"332_CR39","doi-asserted-by":"crossref","unstructured":"North American Menopause Society: The 2012 hormone therapy position statement of the North American Menopause Society. 2012. Journal. 19: p. 257","DOI":"10.1097\/gme.0b013e31824b970a"},{"key":"332_CR40","unstructured":"Pup D, Lino B, Massimiliano DF, Raffaele C, Carla, et al. (2014) Nomegestrol acetate\/estradiol hormonal oral contraceptive and breast cancer risk. Anti-Cancer Drugs 25(7):745\u2013750"},{"issue":"7","key":"332_CR41","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1093\/jnci\/djs014","volume":"104","author":"RT Chlebowski","year":"2012","unstructured":"Chlebowski RT, Anderson GL (2012) Changing concepts: menopausal hormone therapy and breast cancer. J Natl Cancer Inst 104(7):517\u2013527","journal-title":"J Natl Cancer Inst"},{"key":"332_CR42","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","volume":"291","author":"GL Anderson","year":"2004","unstructured":"Anderson GL, Women\u2019s Health Initiative steering committee (2004) Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women\u2019s Health Initiative randomized controlled trial. JAMA 291:1701\u20131712","journal-title":"JAMA"},{"issue":"1","key":"332_CR43","first-page":"101","volume":"107","author":"A Fournier","year":"2008","unstructured":"Fournier A, Bernio F, Clavel-Chapelon F (2008) Unequal risks for BC associated with different hormone replacement therapies: results from the E3N cohort study. BC Res Treat 107(1):101\u2013111","journal-title":"BC Res Treat"},{"issue":"1","key":"332_CR44","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/AOG.0b013e31818e8cd6","volume":"113","author":"H Lyytinen","year":"2009","unstructured":"Lyytinen H, Pukkala E, Ylikorkala O (2009) Breast cancer risk in postmenopausal women using estradiol\u2013progestogen therapy. Obstet Gynecol 113(1):65\u201373","journal-title":"Obstet Gynecol"},{"issue":"14","key":"332_CR45","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1001\/jama.295.14.1647","volume":"295","author":"ML Stefanick","year":"2006","unstructured":"Stefanick ML, Anderson GL, Margolis KL, Hendrix SL, Rodabough RJ, Paskett ED, Lane DS, Hubbell FA, Assaf AR, Sarto GE, Schenken RS, Yasmeen S, Lessin L, Chlebowski RT (2006) Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy. JAMA 295(14):1647\u20131657","journal-title":"JAMA"},{"issue":"2","key":"332_CR46","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s10549-006-9276-y","volume":"101","author":"CE Wood","year":"2007","unstructured":"Wood CE, Register TC, Lees CJ, Chen H, Kimrey S, Mark Cline J (2007) Effects of estradiol with micronized progesterone or medroxyprogesterone acetate on risk markers for breast cancer in postmenopausal monkeys. Breast Cancer Res Treat 101(2):125\u2013134","journal-title":"Breast Cancer Res Treat"},{"key":"332_CR47","doi-asserted-by":"crossref","unstructured":"Beaber, Elisabeth F, Malone, Kathleen E, Tang, Mei-Tzu Chen, Barlow, William E, et al. (2014) Oral contraceptives and breast cancer risk overall and by molecular subtype among young women. Cancer Epidemiology and Prevention Biomarkers","DOI":"10.1158\/1055-9965.EPI-13-0944"},{"issue":"4","key":"332_CR48","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1158\/1055-9965.EPI-08-1005","volume":"18","author":"JM Dolle","year":"2009","unstructured":"Dolle JM, Daling JR, White E, Brinton LA, Doody DR, Porter PL, Malone KE (2009) Risk factors for triple-negative breast cancer in women under the age of 45 years. Cancer Epidemiology and Prevention Biomarkers. 18(4):1157\u20131166","journal-title":"Cancer Epidemiology and Prevention Biomarkers."},{"issue":"8","key":"332_CR49","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s10552-014-0394-2","volume":"25","author":"K Elebro","year":"2014","unstructured":"Elebro K, Butt S, Dorkhan M, Jernstr\u00f6m H, Borgquist S (2014) Age at first childbirth and oral contraceptive use are associated with risk of androgen receptor-negative breast cancer: the Malm\u00f6 diet and cancer cohort. Cancer Causes Control 25(8):945\u2013957","journal-title":"Cancer Causes Control"},{"issue":"6","key":"332_CR50","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1093\/jnci\/djr030","volume":"103","author":"AI Phipps","year":"2011","unstructured":"Phipps AI, Chlebowski RT, Prentice R, McTiernan A, Wactawski-Wende J, Kuller LH, Adams-Campbell LL, Lane D, Stefanick ML, Vitolins M, Kabat GC, Rohan TE, Li CI (2011) Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer. J Natl Cancer Inst 103(6):470\u2013477","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"332_CR51","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1186\/1471-2407-13-584","volume":"13","author":"R Ritte","year":"2013","unstructured":"Ritte R, Tikk K, Lukanova A, Tj\u00f8nneland A, Olsen A, Overvad K, Dossus L, Fournier A, Clavel-Chapelon F, Grote V, Boeing H, Aleksandrova K, Trichopoulou A, Lagiou P, Trichopoulos D, Palli D, Berrino F, Mattiello A, Tumino R, Sacerdote C, Quir\u00f3s JR, Buckland G, Molina-Montes E, Chirlaque MD, Ardanaz E, Amiano P, Bueno-de-Mesquita HB, van Gils CH, Peeters PHM, Wareham N, Khaw KT, Key TJ, Travis RC, Weiderpass E, Dumeaux V, Lund E, Sund M, Andersson A, Romieu I, Rinaldi S, Vineis P, Merritt MA, Riboli E, Kaaks R (2013) Reproductive factors and risk of hormone receptor positive and negative breast cancer: a cohort study. BMC Cancer 13(1):584","journal-title":"BMC Cancer"},{"issue":"5","key":"332_CR52","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/bjc.2013.807","volume":"110","author":"ME Work","year":"2014","unstructured":"Work ME, John EM, Andrulis IL, Knight JA, Liao Y, Mulligan AM, Southey MC, Giles GG, Dite GS, Apicella C, Hibshoosh H, Hopper JL, Terry MB (2014) Reproductive risk factors and oestrogen\/progesterone receptor-negative breast cancer in the Breast Cancer Family Registry. Br J Cancer 110(5):1367\u20131377","journal-title":"Br J Cancer"},{"issue":"8","key":"332_CR53","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1093\/annonc\/mdr304","volume":"22","author":"A Goldhirsch","year":"2011","unstructured":"Goldhirsch A, Wood WC, Coates AS, Gelber RD, Th\u00fcrlimann B, Senn H-J, Panel members (2011) Strategies for subtypes\u2014dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol 22(8):1736\u20131747","journal-title":"Ann Oncol"},{"key":"332_CR54","unstructured":"Lancet (1996) Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. 347: p. 1713\u201327"},{"issue":"15","key":"332_CR55","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1016\/j.ejca.2005.03.035","volume":"41","author":"H Jernstr\u00f6m","year":"2005","unstructured":"Jernstr\u00f6m H, Loman N, Johannsson OT, Borg \u00c5, Olsson H (2005) Impact of teenage oral contraceptive use in a population-based series of early-onset breast cancer cases who have undergone BRCA mutation testing. Eur J Cancer 41(15):2312\u20132320","journal-title":"Eur J Cancer"},{"issue":"3","key":"332_CR56","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s10549-013-2823-4","volume":"143","author":"J Kotsopoulos","year":"2014","unstructured":"Kotsopoulos J, Lubinski J, Moller P, Lynch HT et al (2014) Timing of oral contraceptive use and the risk of breast cancer in BRCA1 mutation carriers. Breast Cancer Res Treat 143(3):579\u2013586","journal-title":"Breast Cancer Res Treat"},{"key":"332_CR57","unstructured":"Janssen Pharmaceutical, Inc, 2015, Ortho Novum and Modicon (norethindrone and ethinyl estradiol) package insert"},{"key":"332_CR58","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.steroids.2011.03.001","volume":"76","author":"D Africander","year":"2011","unstructured":"Africander D, Verhoog N, Hapgood J (2011) Molecular mechanisms of steroid receptor-mediated actions by synthetic progestins used in HRT and contraception. Steroids 76:636\u2013652","journal-title":"Steroids"},{"key":"332_CR59","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.steroids.2003.08.003","volume":"68","author":"F Stanczyk","year":"2003","unstructured":"Stanczyk F (2003) All progestins are not created equal. Steroids 68:879\u2013890","journal-title":"Steroids"},{"key":"332_CR60","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1093\/oxfordjournals.aje.a010265","volume":"151","author":"WY Huang","year":"2000","unstructured":"Huang WY, Newman B, Millikan RC, Schell MJ, Hulka BS, Moorman PG (2000) Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status. Am J Epidemiol 151:703\u2013714","journal-title":"Am J Epidemiol"},{"key":"332_CR61","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1002\/ijc.22970","volume":"121","author":"C Sweeney","year":"2007","unstructured":"Sweeney C, Giuliano AR, Baumgartner KB, Byers T, Herrick JS, Edwards SL, Slattery ML (2007) Oral, injected and implanted contraceptives and breast cancer risk among U.S. Hispanic and non-Hispanic white women. Int J Cancer 121:2517\u20132523","journal-title":"Int J Cancer"},{"key":"332_CR62","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1158\/0008-5472.CAN-09-3460","volume":"70","author":"H Ma","year":"2010","unstructured":"Ma H, Wang Y, Sullivan-Halley J, Weiss L, Marchbanks PA, Spirtas R, Ursin G, Burkman RT, Simon MS, Malone KE, Strom BL, McDonald JA, Press MF, Bernstein L (2010) Use of four biomarkers to evaluate the risk of breast cancer subtypes in the women\u2019s contraceptive and reproductive experiences study. Cancer Res 70:575\u2013587","journal-title":"Cancer Res"}],"container-title":["Hormones and Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12672-018-0332-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-018-0332-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-018-0332-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T18:59:36Z","timestamp":1661021976000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12672-018-0332-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,23]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["332"],"URL":"https:\/\/doi.org\/10.1007\/s12672-018-0332-y","relation":{},"ISSN":["1868-8497","1868-8500"],"issn-type":[{"value":"1868-8497","type":"print"},{"value":"1868-8500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,23]]},"assertion":[{"value":"20 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Appropriate IRB approval was obtained for the Clinical Breast Care Project (CBCP) from the study sites at the Walter Reed National Military Medical Center and Windber Research Institute\/Windber Medical Center. IRB approval was also obtained from Duquesne University School of Pharmacy and Division of Pharmaceutical, Administrative and Social Sciences.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The identification of specific products, scientific instrumentation, or organization is considered an integral part of the scientific endeavor and does not constitute endorsement or implied endorsement on the part of the authors, Department of Defense, or any component agency. The views expressed in this manuscript are those of the authors and do not reflect the official policy of the Department of Army\/Navy\/Air Force, Department of Defense, or US Government.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}